Anaplastic Oligodendroglioma - 21 Studies Found
| Completed |
: Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma :
: Drug: Etirinotecan pegol Other Name: NKTR-102 |
| Not yet recruiting |
: Phase 1 Two Part Dose Escalation Trial of RRx-001 + Radiation + Temozolomide and RRx-001 + Temozolomide Post-RT In Newly Diagnosed Glioblastoma and Anaplastic Gliomas :
|
| Terminated |
: Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme. :
|
| Recruiting |
: Carboplatin in Treating Patients With Recurrent High-Grade Gliomas :
|
| Completed |
: A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas :
: Drug: Nanoliposomal CPT-11 Depending on UGT1A1 genotyping status, patients are either given a starting d |
| Completed |
: A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas : Glioma : 2007-09-07 :
|
| Suspended |
: Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme :
: |
| Terminated |
: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas :
|
| Active, not recruiting |
: Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors :
|
| Terminated |
: RO4929097 in Treating Patients With Recurrent Invasive Gliomas :
: 2010-12-31 : |